175 results on '"Kuligina E"'
Search Results
2. Cytotoxic effect of the VVGMCSF-Lact oncolytic virus against 3D cultures of human glioblastoma cells U-87 MG
3. Antitumor Effect of Vaccinia Virus Double Recombinant Strains Expressing Genes of Cytokine GM-CSF and Oncotoxic Peptide Lactaptin
4. Tumor Specific Peptides Selected for Targeted Delivery of Therapeutic Agents to Glioma Human Cells
5. ANTITUMOR DRUG BASED ON THE GENE-MODIFIED VACCINIA VIRUS VV-GMCSF-Lact
6. Antimetastatic Effect of Liposomal Recombinant Lactaptin
7. Circular RNAs of human blood cells, plasma, and plasma subfractions
8. P1.09B.01 Surgical Reduction at the Peak of Response Before Disease Progression in Patients with Metastatic EGFR-Mutated Lung Cancer
9. Antitumor Effect of Vaccinia Virus Double Recombinant Strains Expressing Genes of Cytokine GM-CSF and Oncotoxic Peptide Lactaptin
10. Highly effective production of biologically active, secreted, human granulocyte-macrophage colony-stimulating factor by recombinant vaccinia virus
11. Penetration of the peptide lactaptin into human cancer cells
12. Effect of recombinant nucleophosmin 1 analogue on artificial RNA internalization into human adenocarcinoma MCF-7 cells
13. 175 Cost-efficient analysis of BRCAness status in high-grade serous ovarian carcinomas
14. Analysis of biochemical markers of MCF-7 cell apoptosis induced by a recombinant analogue of lactaptin
15. Development of targeted delivery ways for antitumor peptide lactaptin: MON-460
16. Ribonucleic acids of circulating complexes from human blood plasma: MON-431
17. Artificial analogues of small nucleolar RNAs modulate the gene expression in human cells: MON-405
18. Lactaptin is a human milk protein inducing apoptosis of MCF-7 adenocarcinoma cells
19. Oligonucleosomal DNA Fragmentation in MCF-7 Cells Undergoing Palmitate-Induced Apoptosis
20. Programmed tumor cells death induced by recombinant analog of lactaptin: SW04.S16–173
21. Prospects of anticancer therapy by lactaptin: SW04.S16–139
22. Targeted delivery of antitumor peptide lactaptin to tumors: SW04.S16–129
23. Comprehensive analysis of artificial box C/D RNAs action on human cells: SW01.S2–45
24. Small non-coding RNAs of human blood plasma of healthy donors and patients with non-small cell lung cancer: SW01.S2–51
25. TECHNICAL ASPECTS OF LIQUID BIOPSY: INFLUENCE OF PREANALYTICAL PARAMETERS ON THE CONCENTRATION OF CIRCULATING TUMOR DNA IN PLASMA OF CANCER PATIENTS
26. COMPARATIVE ANALYSIS OF THE BINDING EFFICIENCY OF TUMOR- TARGETING PHAGE PARTICLES INTO CANCER CELLS AND HEALTH BRAIN CELLS
27. RECOMBINANT VACCINIA VIRUS VV-GMCSF-LACT FOR HUMAN GLIOBLASTOMA TREATMENT
28. CAR-dependent anti-metastatic activity of modified NK cell line YT
29. Preferential expression of the affected MET allele in lung carcinomas with heterozygous MET exon 14 skipping mutations: Implications for clinical testing
30. Analysis of in vitro cytotoxicity of human NK cell line co-expressing a PSMA-specific CAR and an antitumor agent lactaptin
31. Prospects for the construction of buildings in a spherical form
32. PCR-based detection of EGFR, ALK, KRAS and BRAF mutations in Russian patients with lung adenocarcinoma: a single-center experience
33. NK-cell based delivery of anticancer therapeutics
34. Immunogenicity of recombinant analog of antitumor protein lactaptin
35. Somatic loss of the wild-type BRCA1 allele is not necessarily the first event in the pathogenesis of hereditary ovarian cancer: Implications for novel mechanism of acquired platinum resistance
36. BRCA1 large gene rearrangements (LGRs) in Russian breast cancer patients: the development of the droplet digital PCR assay for LGR detection and the identification of recurrent exon 8 deletions
37. Comparative analysis of lactaptin activity when produced in bacterial or eukaryotic expression systems
38. 1550P - Preferential expression of the affected MET allele in lung carcinomas with heterozygous MET exon 14 skipping mutations: Implications for clinical testing
39. Oligodeoxyadenylate stimulates the protein kinase activity of anti-DNA sIgA from human milk
40. Phage Peptide Libraries As a Source of Targeted Ligands
41. Aluand 7SL RNA analogues suppress MCF-7 cell viability through modulating the transcription of endoplasmic reticulum stress response genes
42. Modified Method of rRNA Structure Analysis Reveals Novel Characteristics of Box C/D RNA Analogues
43. HIGH-EFFECTIVE PRODUCTION OF BIOLOGICALLY ACTIVE SECRETED HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR BY RECOMBINANT VACCINIA VIRUS
44. 69P - NK-cell based delivery of anticancer therapeutics
45. 1658P - Somatic loss of the wild-type BRCA1 allele is not necessarily the first event in the pathogenesis of hereditary ovarian cancer: Implications for novel mechanism of acquired platinum resistance
46. 1263P - BRCA1 large gene rearrangements (LGRs) in Russian breast cancer patients: the development of the droplet digital PCR assay for LGR detection and the identification of recurrent exon 8 deletions
47. 956: Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations
48. Alu- and 7SL RNA Analogues Suppress MCF-7 Cell Viability through Modulating the Transcription of Endoplasmic Reticulum Stress Response Genes
49. Analogues of Artificial Human Box C/D Small Nucleolar RNA As Regulators of Alternative Splicing of a pre-mRNA Target
50. 1051 POSTER High Level of MiR-21, MiR-10b and MiR-31 Expression in Bilateral Versus Unilateral Breast Carcinomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.